1 recruiting, 1 unknown. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
Follow Aventusoft, LLC.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG Hemotag - Diabetes Mellitus Type 2, Cardiovascular Diseases | Recruiting | Aventusoft, LLC. | 189 | 2024-03-14 | 2024-08-23 | |
| HEMOTAG® Assessment for Short-term Outcomes of Heart Failure Standard of Care with Hemotag - Heart Failure (HF) | Not applicable | Unknown | Aventusoft, LLC. | 420 | 2022-01-31 | 2024-08-21 |
Cardiovascular Diseases (1) · Cerebrovascular Disorders (1) · Coronary Artery Disease (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Heart Failure (1) · Peripheral Arterial Disease (1)
United States (2)
R44HL145941 (1), R44HL149561 (1)